Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVID-19 vaccination immune response and safety in chronic kidney disease, dialysis, and kidney transplant patients
NL-OMON51071Phase 4Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Feb 2021
- Countries
- 1
01
Overview
Phase 4, open-label trial in coronavirus disease 2019 (COVID-19), sponsored by University Medical Center Groningen. Started Feb 2021; status: active, not recruiting.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NL-OMON51071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51071.